More Medicine Goes Off Limits in Drug-Price Showdown
This article is for subscribers only.
Steve Miller is waging war on high-priced medicine, guiding decisions to ban drugs from the health plans of millions of Americans and sending companies reeling in a $270 billion market.
He and his colleagues at Express Scripts Holding Co. say they are just getting started.